** Shares of Aroa Biosurgery Ltd ARX.AX fall as much as
6.9% to A$0.940
** Stock set to mark worst day since Aug. 29, 2022, if
current losses hold
** Co posts FY23 normalised loss before income tax of NZ$0.9
mln ($541,268.15), but narrower than loss of NZ$5.6 mln in FY22
** Says audited full year product revenue came in at NZ$60.5
mln, reflecting a 55% increase
** Stock has fallen 6.5% this year, as of last close
($1 = 1.6627 New Zealand dollars)
(Reporting by Nausheen Thusoo in Bengaluru)
((Nausheen.Thusoo@thomsonreuters.com;))